Dr. Sanjay Maraboyina
Claim this profileUniversity of Arkansas for Medical Sciences
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
9 reported clinical trials
37 drugs studied
Affiliated Hospitals
Clinical Trials Sanjay Maraboyina is currently running
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
More about Sanjay Maraboyina
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Sanjay Maraboyina has experience with
- Stereotactic Body Radiation Therapy
- Atezolizumab
- Apalutamide
- Degarelix
- Histrelin
- Bicalutamide
Breakdown of trials Sanjay Maraboyina has run
Prostate Cancer
Prostate Adenocarcinoma
Lung Cancer
Prostatic Neoplasm
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Sanjay Maraboyina specialize in?
Is Sanjay Maraboyina currently recruiting for clinical trials?
Are there any treatments that Sanjay Maraboyina has studied deeply?
What is the best way to schedule an appointment with Sanjay Maraboyina?
What is the office address of Sanjay Maraboyina?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.